ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $786.72 million. The enterprise value is $611.15 million.

Market Cap	786.72M
Enterprise Value	611.15M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 36.52 million shares outstanding. The number of shares has increased by 316.83% in one year.

Current Share Class	36.52M
Shares Outstanding	36.52M
Shares Change (YoY)	+316.83%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	2.48%
Owned by Institutions (%)	51.12%
Float	18.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.62
P/TBV Ratio	3.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.34, with a Debt / Equity ratio of 0.00.

Current Ratio	14.34
Quick Ratio	13.63
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.00% and return on invested capital (ROIC) is -24.10%.

Return on Equity (ROE)	-49.00%
Return on Assets (ROA)	-23.10%
Return on Invested Capital (ROIC)	-24.10%
Return on Capital Employed (ROCE)	-49.57%
Revenue Per Employee	n/a
Profits Per Employee	-$2.45M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.76%
50-Day Moving Average	21.82
200-Day Moving Average	24.47
Relative Strength Index (RSI)	47.06
Average Volume (20 Days)	431,393

Short Selling Information

The latest short interest is 5.63 million, so 15.42% of the outstanding shares have been sold short.

Short Interest	5.63M
Short Previous Month	5.02M
Short % of Shares Out	15.42%
Short % of Float	31.08%
Short Ratio (days to cover)	14.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-100.41M
Pretax Income	n/a
Net Income	-127.46M
EBITDA	n/a
EBIT	-100.41M
Earnings Per Share (EPS)	-$3.78

Balance Sheet

The company has $176.08 million in cash and $138,000 in debt, giving a net cash position of $175.94 million or $4.82 per share.

Cash & Cash Equivalents	176.08M
Total Debt	138,000
Net Cash	175.94M
Net Cash Per Share	$4.82
Equity (Book Value)	202.54M
Book Value Per Share	5.95
Working Capital	172.83M

Cash Flow

Operating Cash Flow	-119.59M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-316.83%
Shareholder Yield	-316.83%
Earnings Yield	-16.19%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $38.38, which is 78.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.38
Price Target Difference	78.18%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	13.19%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1